Genitourinary Radiology: Page 56

EDAP products registered in France
By AuntMinnie.com staff writers
EDAP TMS has announced that its Sonolith lithotripter products, including Sonolith i-sys and Sonolith i-move, have been exclusively registered by UGAP, the French Public Purchasing Agency.
December 6, 2010
Toshiba touts noncontrast renal MRA trial
By AuntMinnie.com staff writers
At the RSNA 2010 meeting in Chicago, Toshiba America Medical Systems announced a multicenter clinical trial designed to establish the clinical efficacy of noncontrast renal MR angiography (MRA) using its time-spatial labeling inversion pulse (Time-SLIP) technology.
November 29, 2010
Positive results reported with stereotactic RT for prostate cancer
By Cynthia E. Keen
The verdict won't be in for years. But early outcomes were encouraging for prostate cancer patients treated with stereotactic radiation therapy (RT), according to research presented at the American Society for Radiation Oncology annual meeting held earlier this month in San Diego.
November 22, 2010
Radiofrequency ablation safe for multifocal renal neoplasms
By Eric Barnes
Friday, December 3 | 10:40 a.m.-10:50 a.m. | SST16-02 | Room E353BRadiofrequency ablation is a good renal sparing alternative to surgery for patients with multifocal renal tumors, and the complication rate is no higher than for patients with single tumors, researchers from Wake Forest University Baptist Medical Center in Winston-Salem, NC, have found.
November 18, 2010
CT-guided cryoablation safe for kidney lesions
By Eric Barnes
Friday, December 3 | 10:30 a.m.-10:40 a.m. | SST16-01 | Room E353BThere's more than one way to kill a kidney cancer without surgery. Freezing renal tumors percutaneously is safe and effective and delivers very low complication rates, say researchers from Duke University in Durham, NC.
November 18, 2010
Same-day renal function testing helps manage contrast dose for CT, MRI
By Kate Madden Yee
Monday, November 29 | 11:00 a.m.-11:10 a.m. | SSC07-04 | Room S102DTesting patients' renal function the same day they are scheduled for MRI or CT exams helps clinicians better manage contrast dose, according to researchers from the University of Rochester in Rochester, NY.
November 16, 2010
FDG-PET/CT aids evaluation of bladder cancer patients
By Wayne Forrest
Wednesday, December 1 | 3:30 p.m.-3:40 p.m. | SSM18-04 | Room S505ABFDG-PET/CT is helpful in accurately assessing disease and can provide significant prognostic information in patients with urothelial cancer. So concluded researchers from Johns Hopkins University in Baltimore in their study scheduled to be presented Wednesday afternoon at RSNA 2010.
November 15, 2010
F-18 choline PET/CT outpaces whole-body MRI in recurrent prostate cancer
By Wayne Forrest
Sunday, November 28 | 12:05 p.m.-12:15 p.m. | SSA18-09 | Room S505ABPreliminary results of an Italian study show that while whole-body MRI did not match accuracy levels of F-18 choline PET/CT in detecting the local recurrence of prostate cancer, whole-body MRI is still a promising tool in restaging patients with the disease.
November 15, 2010
How to be efficient in reading VC CAD
By Erik L. Ridley
Education Exhibit | LL-GIE2302 | Lakeside Learning CenterVisitors to this exhibit will receive practical tips on getting the most from their virtual colonoscopy computer-aided detection (CAD) software.
November 14, 2010
Automatic segmentation technique shows promise for CT urograms
By Erik L. Ridley
Tuesday, November 30 | 11:20 a.m.-11:30 a.m. | SSG13-06 | Room S403AResearchers from the University of Michigan in Ann Arbor have developed an automatic bladder lesion segmentation technique for CT urograms. Presenter Lubomir Hadjiiski, PhD, will share the details of their study in this session on Tuesday.
November 14, 2010
Automatic segmentation technique shows promise for CT urograms
By Erik L. Ridley
Tuesday, November 30 | 11:20 a.m.-11:30 a.m. | SSG13-06 | Room S403AIn this paper, researchers from the University of Michigan in Ann Arbor will share details on their automatic bladder lesion segmentation technique for CT urograms.
November 10, 2010
PSA screening, aspirin may reduce prostate cancer deaths
By Cynthia E. Keen
Screening men who have been treated for prostate cancer based on prostate-specific antigen (PSA) levels can lower deaths by reducing the risk of metastasis within 10 years of treatment, according to a study to be presented at the upcoming American Society for Radiation Oncology meeting in San Diego.
October 25, 2010
Previous Page
Page 56 of 93
Next Page